Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Jang K‐S, Song Y S, Jang S‐H, Min K‐W, Na W, Jang S M, Jun Y J, Lee K H, Choi D & Paik S S (2010) Histopathology56, 229–239 Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma Aims: Tumour suppressor phosphatase and tensin homologue (PTEN) is an important negative regulator for the PIP3/Akt signalling pathway that promotes cell proliferation and inhibits apoptosis. Inactivation of PTEN by mutation, deletion and promoter hypermethylation has been demonstrated in a range of cancers. The aim was to investigate whether the loss of nuclear PTEN protein expression correlates with conventional clinicopathological parameters and patient survival. Methods and results: Immunohistochemistry staining for PTEN was performed on a tissue microarray of 19 samples of normal colonic mucosa, 14 adenomatous polyps, 482 adenocarcinomas and 56 metastatic lymph nodes. All 19 normal colonic mucosa samples (100%) were positive and 12 (85.7%) out of 14 adenomatous polyps were positive for PTEN. However, only 241 (50.0%) of the 482 colorectal adenocarcinomas and 26 (46.4%) of the 56 metastatic lymph nodes were positive for PTEN. Loss of PTEN expression was related to defective mismatch repair protein expression and colonic localization rather than rectal localization. On univariate survival analysis, patients with PTEN− adenocarcinoma revealed a poor overall and disease‐free survival (P = 0.030 and P = 0.046, respectively). On multivariate analysis, a significant difference was observed in patients with stage II cancer that was not observed in other stages. Conclusions: Nuclear PTEN expression gradually decrease during the normal–adenoma–adenocarcinoma–metastasis sequence, which suggests an important role for PTEN in carcinogenesis. Moreover, loss of nuclear PTEN expression was a marker of poor clinical outcome in patients with stage II colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748 · cited 2×
“However, the presence of PTEN in the nucleus has been recently investigated, and its tumour-suppressive function has become accepted.(38,40) Previous studies using PTEN immunohistochemistry in colorectal tissue support the notion that nuclear expression may be more important than cytoplasmic localization.”
BackgroundResultPTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
Frattini, M., Saletti, P., Romagnani, E., Martin, V, Molinari, F., Ghisletta, M., Camponovo, A., Etienne, L. L., Cavalli, F., & Mazzucchelli, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604009 · Cited by 540 · cited 1×
“In a study of 27 cetuximab-treated metastatic colorectal cancer patients, 10 of 16 patients with normally expressed PTEN protein achieved a partial response to cetuximab, whereas none of the 11 patients with loss of PTEN had any benefit.(37) In this study, we investigated nuclear PTEN protein expression, determined by…”
BackgroundJhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y.-H., Byun, D.-S., Nasser, S., Arango, D., Shin, J., Klampfer, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5659 · Cited by 460 · cited 1×
“PTEN expression status also predicted the responsiveness to cetuximab therapy, which targets the epidermal growth factor receptor signalling pathway.(36) In a study of 27 cetuximab-treated metastatic colorectal cancer patients, 10 of 16 patients with normally expressed PTEN protein achieved a partial response to cetux…”
BackgroundGoel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302 · cited 4×
“Moreover, epigenetic silencing of PTEN by promoter hypermethylation has been observed in sporadic colorectal cancers, especially in the microsatellite instability-high tumours.(27) The prognostic and predictive value of PTEN expression has been investigated in several human cancers.”
BackgroundResultInfluential
Cited by
Mechanisms of PTEN loss in cancer: It’s all about diversity
Álvarez-Garcia, V., Tawil, Y., Wise, H. M., & Leslie, N. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.001 · Cited by 401
Song, M., Chen, D., Lu, B., Wang, C., Zhang, J., Huang, L., Wang, X., Timmons, C. L., Hu, J., Liu, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065821 · Cited by 266
Cathomas, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00035 · Cited by 133
“In the PI3K/AKT/mTOR pathway, the tumor suppressor gene PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a direct antagonist and mutation or loss of PTEN expression has shown to be correlated with a poor outcome in CRC (10, 11).”
BackgroundPrecise definition of PTEN C-terminal epitopes and its implications in clinical oncology
Mingo, J., Luna, S., Gaafar, A., Nunes-Xavier, C. E., Torices, L., Mosteiro, L., Ruiz, R., Guerra, I., Llarena, R., Angulo, J. C., et al. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0083-4 · Cited by 22
Metadata
- Authors
- Jang, K., Song, Y. S., Jang, S., Min, K., Na, W., Jang, S. M., Jun, Y. J., Lee, K. H., Choi, D., & Paik, S. S.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2009-12-23
- Volume
- 56
- Issue
- 2
- Pages
- 229-239
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2160797588
- Cited by
- 74
- References
- 5
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. https://app.cochat.ai/papers/10.1111/j.1365-2559.2009.03468.x
- The paper
- Jang, K., Song, Y. S., Jang, S., Min, K., Na, W., Jang, S. M., Jun, Y. J., Lee, K. H., Choi, D., & Paik, S. S. (2010). Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology. https://doi.org/10.1111/j.1365-2559.2009.03468.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.